Drug Availability

HPS Pharmacies wish to advise that Merck Sharp & Dohme (Australia) Pty Ltd are experiencing an interruption to the supply of:

Sinemet CR® (levodopa/carbidopa) 200mg/50mg modified release tablets
ARTG 171694

This product is in short supply due to manufacturing issues.

Medsurge has been able to arrange for supply of an alternative product Sinemet CR® 50mg/200mg Prolonged-Release Tablets pack of 60 (UK) on a temporary basis. This product is not registered for use in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under Section 19A of the Therapeutic Goods Act 1989 until 31/01/2019 for the following indication(s):

  • Idiopathic parkinsonism, where standard formulations containing levodopa/carbidopa have produced inadequate control. Experience is limited with Sinemet CR® in patients who have not been treated with levodopa before.

Please retain this notice in a prominent position, including in other related business units as a reminder for all staff members.

Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Merck Sharp & Dohme (Australia) Pty Ltd on (02) 8988 8000.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates